Clinical Trials for Avidity Biosciences

Explore 7 clinical trials worldwide

Showing 1-7 of 7 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Avidity Biosciences

Clinical Trials (7)

Global Open-Label Extension Study of Del-desiran for the Treatment of DM1

PHASE3Enrolling by invitation

217 participants

Started: Jul 25, 2025 · Completed: Oct 31, 2030

8 conditions1 sponsor9 locations

A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD

PHASE3Recruiting

200 participants

Started: Jun 10, 2025 · Completed: Jul 31, 2028

17 conditions1 sponsor14 locations

Phase 2 Open-label Extension Study of AOC 1020 in Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)

PHASE2Enrolling by invitation

84 participants

Started: Jul 25, 2024 · Completed: Apr 30, 2028

27 conditions1 sponsor17 locations

Global Study of Del-desiran for the Treatment of DM1

PHASE3Active, not recruiting

159 participants

Started: May 30, 2024 · Completed: Sep 30, 2026

10 conditions1 sponsor34 locations

Ph2 Open-label Study of AOC 1044 in Duchenne Muscular Dystrophy Participants With Mutations Amenable to Exon44 Skipping

PHASE2Active, not recruiting

39 participants

Started: Jan 22, 2024 · Completed: Jul 31, 2027

4 conditions1 sponsor10 locations

Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)

PHASE1/PHASE2Active, not recruiting

90 participants

Started: Apr 4, 2023 · Completed: Apr 30, 2027

27 conditions1 sponsor17 locations

Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)

450 participants

Started: Dec 15, 2020 · Completed: Jan 31, 2028

1 condition12 sponsors20 locations